appendix 4d - blackmores

Appendix 4D HALF-YEAR REPORT

Blackmores Limited - ACN 009 713 437 For the period ended 31 December 2018

This Half-Year Report is provided to the Australian Stock Exchange (ASX) under

ASX Listing Rule 4.2A

RESULTS FOR ANNOUNCEMENT TO THE MARKET

Current Reporting Period: Half-Year ended 31 December 2018

Previous Corresponding Period: Half-Year ended 31 December 2017

Revenue and Net Profit Amount Up / Down Movement

$’000

Revenue from ordinary activities

319,389

up

11.1%

Profit after tax attributable to members

34,325

up 0.4%

Net profit attributable to members

34,325

up 0.4%

Dividend Information

Amount per

Security

Franked Amount per Security

Tax Rate for Franking

Interim dividend (to be paid 20 March 2019)

150¢ 150¢ 30%

The Company’s Dividend Reinvestment Plan (DRP) remains active. The current discount applying to shares issued under the Plan is 2.5%. The last date for receipt of a valid election notice by our Share Registry for participation in the Plan is 6 March 2019. The DRP pricing period will be the five trading days from 6 March 2019 to 12 March 2019. Any shares issued pursuant to the Plan will rank equally with other existing shares Interim Dividend Dates

Ex-dividend date 4 March 2019

Record date 5 March 2019

Payment date

20 March 2019

31 December

2018 31 December

2017 Net tangible assets per security $7.49 $6.83

Additional Appendix 4D disclosure requirements can be found in the Blackmores Limited Half-Year Report for the period ended 31 December 2018. The Appendix 4D is based on the Blackmores Limited Half-Year Report for the period ended 31 December 2018 which has been reviewed by Deloitte Touche Tohmatsu. This should be read in conjunction with the most recent Annual Financial Report as at and for the year ended 30 June 2018.

Financial Report FOR THE HALF-YEAR ENDED 31 DECEMBER 2018

1 Directors’ Report3 Auditor’s Independence Declaration4 Independent Auditor’s Review Report6 Directors’ Declaration7 CondensedConsolidatedStatementofProfitorLoss and Other Comprehensive Income8 Condensed Consolidated Statement of Financial Position 9 Condensed Consolidated Statement of Changes in Equity 10 Condensed Consolidated Statement of Cash Flows 11 Notes to the Condensed Consolidated Financial Statements

Contents

1 B L A C K M O R E S F I N A N C I A L R E P O R T F O R T H E H A L F - Y E A R E N D E D 3 1 D E C E M B E R 2 0 1 8

Directors’ ReportFOR THE HALF-YEAR ENDED 31 DECEMBER 2018

The Directors of Blackmores Limited submit herewith the Financial Report of Blackmores Limited and its subsidiaries (the Group) for the half-year ended 31 December 2018. In order to comply with the provisions of the Corporations Act 2001, the Directors’ Report is as follows:The names of the Directors of the Company during and since the end of the half-year are:Brent Wallace David Ansell John Armstrong Marcus Blackmore Richard Henfrey Jackie McArthur Helen Nash Stephen Chapman (resigned 27 November 2018)

REVIEW OF OPERATIONS AND FINANCIAL RESULTSThe Directors report that revenue for the six months to 31 December 2018 was $319 million, up 11%, delivering a net profit after tax attributable to Blackmores shareholders of $34 million, in line with the profit result delivered in the previous corresponding period due to increased levels of investment, impacting profitability in the short-term.Revenue in Australia and New Zealand (ANZ) of $144 million was up $23 million (or 19%) on the previous corresponding period. Revenue was boosted by Australian retailers more actively targeting export trade to China. The earnings from our business in Australia and New Zealand increased in the half with earnings before interest and taxes (EBIT) of $33 million, up 28% compared to the previous corresponding period.Blackmores remains the number one VDS brand1 in Australia and we continue to benefit from strong sales of new products, including the recently launched ‘Essentials’ range, higher strength magnesium and curcumin for joint health.Our reported China segment sales were down 11% in the half compared to the prior corresponding period, although when China-influenced sales through Australian retailers are taken into account, we estimate growth in sales to Chinese consumers to be around 8%.Contributing to this China result was a channel shift with Australian retailers more directly targeting the China export trade, which has benefited our ANZ segment results. This channel shift was highlighted in quarter one and has continued to accelerate through quarter two.Within the China segment, China in-country sales continued to grow strongly during the half. Sales during Singles Day were up 65% on 2017, with 200,000 products sold. We are investing strongly in our brand in China, including the recent appointment of Shawn Dou as Brand Ambassador.

Blackmores had a major presence at the China International Import Expo (CIIE) in Shanghai, which was attended by an estimated 500,000 visitors.Blackmores’ businesses across Asia recorded strong levels of sales growth. Korea increased 67%, Taiwan 150% and Hong Kong was up 39% on the prior corresponding period.EBIT for Other Asia was up 268% for the half, due to success of NPD and marketing program, distribution and retailer expansion, and improved supply environment.Our joint venture in Indonesia, Kalbe Blackmores Nutrition, continues to grow strongly with sales up 72% in the half. A key driver was the entry into Kimia Farma – Indonesia’s largest pharmacy retail chain.BioCeuticals Group delivered sales growth of 7% and continues to lead in the practitioner category in both product sales and education resources. During the half, BioCeuticals commenced a medicinal cannabis trial for glioblastoma multiform, a form of brain cancer. The trial is running in conjunction with the Prince of Wales Hospital and Endeavour College of Natural Therapies. Endeavour’s Dr Janet Schloss is the lead investigator and neurosurgeon Dr Charlie Teo is the prescribing physician.The Blackmores Institute continues its strong focus on promoting an evidence-based approach to complementary medicine throughout the Asia Pacific region, including the launch of a Green Paper on the Health of Chinese Career Women in collaboration with the prestigious Tsinghua University. The Institute held three health professional symposia with record attendances in Bangkok, Hanoi and Ho Chi Minh City, and Pharmacist Masterclasses on Integrative Prescribing were held around Australia.

FINANCIAL POSITION OF THE GROUPThe Blackmores balance sheet remains in a strong position at the end of the half-year.Total Net Assets increased by $16 million to $210 million in the half. Total Current Assets of the Group were relatively flat and decreased by $1 million to $301 million during the half-year, due to slightly higher inventory levels and sponsorship prepayments offset by lower receivables balances compared to June. Inventory levels at $110 million continue to be closely managed and include higher levels of safety stock. Since June 2018, inventory has grown by a further 6% to support increased sales and better manage risk of supply disruptions.Non-current assets of the Group increased by $14 million to $176 million during the half-year, due the continued investment in our systems and more significantly to reflect the acquisition of the Impromy weight management brand in the half.


Directors’ ReportFOR THE HALF-YEAR ENDED 31 DECEMBER 2018

Current liabilities of the Group decreased by $28 million to $147 million during the half-year, largely due to inventory purchasing cycles.Non-current liabilities of the Group increased during the half-year to $121 million, up $24 million since June 2018, driven by increased borrowings to fund higher working capital requirements and the recent Impromy acquisition.Net debt increases were broadly in line with the increase in Gross Debt, with cash levels increasing by $2 million in the period to $38 million.The Gearing Ratio has increased from 20% to 25% in the period but remains at conservative levels and we have maintained appropriate headroom against all bank covenantsWorking Capital at $118 million has increased by $21 million in the period, driven by the growth in the business and timing of supplier payments.Cash generated from operations of the Group was $34 million, an increase of 22% ($6 million) on the prior corresponding period. Cash conversion for the Group was 60%, which compares favourably to 52% delivered in the prior corresponding period.

DIVIDENDThe amounts paid or declared by way of dividend since the start of the financial year are: • A final dividend of 155 cents per share fully franked in respect

of the year ended 30 June 2018, as detailed in the Directors’ Report for that financial year, was paid on 12 October 2018.

• On 18 February 2019, Directors declared an interim dividend of 150 cents per share fully franked, which is in line with the prior corresponding period. The record date is 5 March 2019 and the dividend is payable on 20 March 2019.

The Dividend Reinvestment Plan is available for the interim dividend, allowing shareholders to reinvest distributions in the Company’s securities and to support the funding of growth initiatives. Shareholders who elect to participate in the DRP will benefit from a 2.5% discount.If you wish to participate in the DRP or change your current nomination, you will need to do so by 5pm (AEDT) on 6 March 2019. Further information is available at www.blackmores.com.au/dividend

SUBSEQUENT EVENTSOther than the declaration of the dividend, the Directors are not aware of any other matter or circumstance that has arisen since the end of the year that has significantly affected, or may significantly affect, the Group’s operations or financial state of affairs in future years.

OUTLOOKOur outlook is for modest full-year revenue growth.However, our China sales in the third quarter are being impacted by continuing changes to the way consumers purchase our products as well as higher inventory in the trade and a general softening of consumer sentiment.As a result, we do not expect the second half profit performance to be ahead of the first half result.Apart from China, all other markets are expected to continue performing well and we expect overall Group sales to improve in the fourth quarter.As our business continues to grow and evolve, we are committed to investing in initiatives to drive our future growth.An efficient operating structure is a critical part of this plan and we are leading a Business Improvement Program across the organisation to target $60 million of savings over the next three years. This work has already commenced. The intention is that savings will be redirected to investment in strategic initiatives, investment in people and capacity, and delivery of overall margin improvement.The Board remains confident in the future long-term growth potential for the Blackmores business.

AUDITOR’S INDEPENDENCE DECLARATIONThe auditor’s independence declaration is included on page 3 of the half-year Financial Report.

ROUNDING OFF AMOUNTSThe Company is a company of the kind referred to in ASIC Corporations Instrument 2016/191, dated 24 March 2016, and in accordance with that Corporations Instrument amounts in the Directors’ Report and the half-year Financial Report are rounded-off to the nearest thousand dollars, unless otherwise indicated.Signed in accordance with a resolution of Directors made pursuant to s.306 (3) of the Corporations Act 2001.

On behalf of the Directors

Brent Wallace ChairmanDated in Sydney, 18 February 2019

1. Nielsen total VDS domestic market data MAT to 31/12/2018.


Auditor’s Independence Declaration


Independent Auditor’s Review Report


The directors declare that: (a) in the directors’ opinion, there are reasonable grounds to believe that the company will be able to pay its debts as and when

they become due and payable; and (b) in the directors’ opinion, the attached financial statements and notes thereto are in accordance with the Corporations Act

2001, including compliance with accounting standards and giving a true and fair view of the financial position and performance of the consolidated entity.

Signed in accordance with a resolution of the directors made pursuant to s.303(5) of the Corporations Act 2001.

On behalf of the Directors

Brent Wallace ChairmanSydney, 18 February 2019

Directors’ Declaration


Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income FOR THE HALF-YEAR ENDED 31 DECEMBER 2018

31 December 31 December 2018 2017 NOTES $’000 $’000

Revenue 2.1 319,389 287,381 Other income 1,057 757 Revenue and other income 320,446 288,138 Raw materials and consumables used 124,184 112,350 Employee benefits expenses 77,877 68,482 Selling and marketing expenses 31,963 24,454 Depreciation and amortisation expenses 5,307 4,287 Operating lease rental expenses 4,767 4,565 Professional and consulting expenses 5,622 4,782 Repairs and maintenance expenses 3,549 3,236 Freight expenses 7,938 6,791 Bank charges 600 505 Licences and registrations 2,028 814 Impairment of financial assets 85 2,798 Other expenses 6,049 5,822 Total expenses 269,969 238,886 Earnings before interest and tax 2.2 50,477 49,252 Interest revenue 167 249 Interest expense (2,412) (2,231)Net interest expense (2,245) (1,982)Profit before tax 48,232 47,270 Income tax expense (14,132) (13,945)Profit after tax 34,100 33,325 Profit/(loss) attributable to: Owners of the parent 34,325 34,180 Non-controlling interests (225) (855) 34,100 33,325 Other comprehensive income Items that may be reclassified subsequently to profit or loss: Exchange differences arising on translation of foreign controlled entities 1,514 967 Net gain/(loss) on hedging instruments entered into for cash flow hedges (net of tax) 1 (36) Other comprehensive income for the period (net of tax) 1,515 931 Total comprehensive income for the period 35,615 34,256 Total comprehensive income attributable to: Owners of the parent 35,838 35,139 Non-controlling interests (223) (883) 35,615 34,256 EARNINGS PER SHARE – Basic earnings per share (cents) 4.3 198.9 198.4 – Diluted earnings per share (cents) 198.2 198.0

Notes to the Condensed Consolidated Financial Statements are included on pages 11 to 20.


Condensed Consolidated Statement of Financial PositionAS AT 31 DECEMBER 2018

31 December 30 June 2018 2018 NOTES $’000 $’000

ASSETS CURRENT ASSETSCash and cash equivalents 38,104 36,468 Receivables 138,928 150,788 Inventories 110,413 103,965 Other assets 13,354 10,811 Derivative assets 5.1 664 475 Total current assets 301,463 302,507 NON-CURRENT ASSETS Property, plant and equipment 78,359 76,261 Investment property 2,160 2,160 Goodwill and intangible assets 3.1 77,316 66,212 Deferred tax assets 13,036 12,590 Other financial assets 1,776 1,520 Amounts advanced to related parties 3,600 3,600 Total non-current assets 176,247 162,343 Total assets 477,710 464,850 LIABILITIES CURRENT LIABILITIES Trade and other payables 131,363 157,868 Current tax liability 2,131 4,246 Provisions 8,782 8,065 Other liabilities 4,098 4,085 Derivative liabilities 5.1 311 203 Total current liabilities 146,685 174,467 NON-CURRENT LIABILITIES Interest-bearing liabilities 4.1 109,000 86,000 Deferred tax liabilities 10,227 9,341 Provisions 1,222 1,229 Other liabilities 814 483 Total non-current liabilities 121,263 97,053 Total liabilities 267,948 271,520 Net assets 209,762 193,330

EQUITY CAPITAL AND RESERVES Issued capital 47,120 37,753 Reserves 5,476 5,926 Retained earnings 156,934 149,196 Equity attributable to shareholders of Blackmores Ltd 209,530 192,875 Equity attributable to non-controlling interests 232 455 Total equity 209,762 193,330



Condensed Consolidated Statement of Changes in Equity FOR THE HALF-YEAR ENDED 31 DECEMBER 2018

EQUITY-SETTLED FOREIGN ATTRIBUTABLE EMPLOYEE CASH FLOW CURRENCY TO OWNERS OF NON- ISSUED BENEFITS HEDGING TRANSLATION RETAINED BLACKMORES CONTROLLING TOTAL CAPITAL RESERVE RESERVE RESERVE EARNINGS LTD INTEREST EQUITY

$’000 $’000 $’000 $’000 $’000 $’000 $’000 $’000

Balance as at 1 July 2017 37,753 5,167 (415) (667) 135,703 177,541 1,278 178,819 Dividends declared - - - - (24,117) (24,117) - (24,117) Profit/(loss) for the period - - - - 34,180 34,180 (855) 33,325 Other comprehensive income/(expense) for the period, net of tax - - (36) 995 - 959 (28) 931 Total comprehensive income for the period - - (36) 995 34,180 35,139 (883) 34,256 Share-based payments expense - 752 - - - 752 - 752 Issue of shares under employee long-term incentive plans (net of on market purchases and tax) - (2,744) - - (6,687) (9,431) - (9,431) Balance as at 31 December 2017 37,753 3,175 (451) 328 139,079 179,884 395 180,279 Balance as at 1 July 2018 37,753 3,739 188 1,999 149,196 192,875 455 193,330 Dividends declared - - - - (26,587) (26,587) - (26,587) Profit/(loss) for the period - - - - 34,325 34,325 (225) 34,100 Other comprehensive income/(expense) for the period, net of tax - - 1 1,512 - 1,513 2 1,515 Total comprehensive income for the period - - 1 1,512 34,325 35,838 (223) 35,615 Share-based payments expense - 628 - - - 628 - 628 Issue of shares under the Dividend Reinvestment Plan (DRP) 6,776 - - - - 6,776 - 6,776 Issue of shares under employee long-term incentive plans (net of on market purchases and tax) 2,591 (2,591) - - - - - - Balance as at 31 December 2018 47,120 1,776 189 3,511 156,934 209,530 232 209,762



Condensed Consolidated Statement of Cash FlowsFOR THE HALF-YEAR ENDED 31 DECEMBER 2018

31 December 31 December 2018 2017 NOTES $’000 $’000

CASH FLOWS FROM OPERATING ACTIVITIESReceipts from customers (net of promotional and other rebates) 374,415 317,987 Payments to suppliers and employees (340,772) (290,313)Cash generated from operations 33,643 27,674 Interest and other costs of finance paid (3,053) (2,763)Income taxes paid (15,596) (16,296)Net cash flows from operating activities 14,994 8,615 CASH FLOWS FROM INVESTING ACTIVITIES Interest received 168 249 Payments for property, plant and equipment (7,802) (6,459)Payments for business combinations 3.1 (8,686) - Payments for intangible assets (1,912) - Proceeds from disposal of property, plant and equipment 13 14 Dividends received - 36 Amounts advanced to related parties - 285 Net cash used in investing activities (18,219) (5,875) CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from bank borrowings 506,000 175,080 Repayment of bank borrowings (483,000) (154,000)Proceeds from other borrowings 279 - Dividends paid 4.2 (19,811) (24,117)Net cash used in financing activities 3,468 (3,037) Net increase in cash and cash equivalents 243 (297)Cash and cash equivalents at the beginning of the period 36,468 34,251 Effects of exchange rate changes on the balance of cash held in foreign currencies 1,393 365 Cash and cash equivalents at the end of the period 38,104 34,319



Notes to the Condensed Consolidated Financial StatementsFOR THE HALF-YEAR ENDED 31 DECEMBER 2018



1.1 REPORTING ENTITYBlackmores Limited is a company domiciled in Australia. The Consolidated Interim Financial Report (Financial Report) of Blackmores as at and for the half-year ended 31 December 2018 comprises Blackmores and its subsidiaries (the Group).The Consolidated Annual Financial Report of the Group for the financial year ended 30 June 2018 is available upon request from the registered office of Blackmores at 20 Jubilee Avenue, Warriewood, NSW 2102 or online at blackmores.com.au.

1.2 STATEMENT OF COMPLIANCE The half-year Financial Report is a General Purpose Financial Report prepared in accordance with the Corporations Act 2001 and AASB 134 ‘Interim Financial Reporting’. Compliance with AASB 134 ‘Interim Financial Reporting’ ensures compliance with the International Financial Reporting Standard IAS 34 ‘Interim Financial Reporting’. The half-year report does not include notes of the type normally included in an Annual Financial Report and should be read in conjunction with the most recent Annual Financial Report as at and for the financial year ended 30 June 2018.

1.3 BASIS OF PREPARATION The half-year Financial Report has been prepared on the basis of historical cost, except certain non-current assets and financial instruments that are measured at revalued amounts or fair values. Historical cost is generally based on the fair values of the consideration given in exchange for assets. All amounts are presented in Australian Dollars unless otherwise noted.In accordance with the Australian Securities and Investments Commission (ASIC) Corporations Instrument 2016/191, the amounts in the Directors’ Report and the half-year Financial Report are rounded off to the nearest thousand dollars, unless otherwise indicated. The accounting policies and methods of computation adopted in the preparation of the half-year Financial Report are consistent with those adopted and disclosed in the Group’s 2018 Annual Financial Report for the financial year ended 30 June 2018, except for the impact of the Standards and Interpretations described below. These accounting policies are consistent with Australian Accounting Standards and with International Financial Reporting Standards.

1.4 ESTIMATES The preparation of the half-year Financial Report requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expenses. Actual results may differ from these estimates. In preparing this half-year Financial Report, the significant judgements made by management in applying the Group’s accounting policies and the key sources of uncertainty in estimation were the same as those that applied to the Annual Financial Report for the financial year ended 30 June 2018.Accounting policies are selected and applied in a manner which ensures that the resulting financial information satisfies the concepts of relevance and reliability, thereby ensuring that the substance of the underlying transactions or other events is reported.

Blackmores Limited (the Company) is a public company listed on the Australian Securities Exchange (trading under the symbol ‘BKL’), incorporated in Australia and operating across Australia, New Zealand and Asia.

Blackmores Limited’s registered office and its principal place of business is as follows:20 Jubilee Avenue, Warriewood, NSW 2102Telephone +61 2 9910 5000

The Group’s principal activity is the development, sales and marketing of health products for humans and animals, including vitamins, and herbal and mineral nutritional supplements.

01GENERAL INFORMATION



1.5 APPLICATION OF NEW AND REVISED ACCOUNTING STANDARDS The Group has adopted all of the new and revised Standards and Interpretations issued by the Australian Accounting Standards Board (the AASB) that are relevant to their operations and effective for the current half-year.New and revised Standards and amendments thereof and interpretations effective for the current reporting period that are relevant to the Group include: • AASB 2014-1 Amendments to Australian Accounting Standards [Part C – Materiality] The adoption of these amendments has not resulted in any changes to the Group’s accounting policies and has no effect on the amounts reported for the current or prior periods.• AASB 9 Financial InstrumentsAASB 9 introduces new requirements for the classification and measurement of financial assets and financial liabilities. This change has no impact on the classification and measurement in the half-year report. AASB 9 changes the calculation of impairment losses in financial assets. It impacts the way the Group calculates the doubtful debt provision, now termed the credit loss allowance. The Group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables.To measure the expected credit losses, trade receivables have been grouped based on shared credit risk characteristics and the days past due. A provision matrix is determined based on historic credit loss rates for each group of customer, adjusted for any material expected changes to the customers’ future credit risk.The impact on the half-year report is immaterial. • AASB 15 Revenue from Contracts with CustomersIn the current year, the Group has applied AASB 15 Revenue from Contracts with Customers (as amended) which is effective for an annual period that begins on or after 1 January 2018. It replaced AASB 118 Revenue and related interpretations. Apart from providing more extensive disclosures for the Group’s revenue transactions, the application of AASB 15 has not had a significant impact on the financial position and/or financial performance of the Group. This is because revenue is recognised at the point control of goods passes to the customer, which is consistent with the point in time of revenue recognition under the old accounting standard AASB 118 Revenue.

Summary of revenue streamsRevenue from sale of goods is reduced for discounts and promotional and other rebates.

REVENUE STREAM WHEN PERFORMANCE OBLIGATION IS SATISFIED

TIMING OF RECOGNITION

Revenue from sale of goods (including sale of goods on consignment)

Delivery of goods to customer and passing of legal title

At the point of delivery

• AASB 16 LeasesAs disclosed in the 30 June 2018 Financial Report, AASB 16 Leases will replace existing accounting requirements for leases under AASB 117 Leases. The Group is continuing to assess the impact of the new requirements on the Group’s Consolidated Financial Statements; however the impact is expected to materially ‘gross-up’ the Group’s Consolidated Statement of Financial Position, impacting key financial ratios. As the assessment develops further, quantitative and qualitative disclosures will be provided.

01GENERAL INFORMATION



2.1 REVENUE AND OTHER INCOME

Consolidated Half-year ended

31 December 31 December 2018 2017 $’000 $’000

Sales (net of discounts) 397,436 351,855 Promotional and other rebates (78,047) (64,474)Revenue 319,389 287,381 Other income 1,057 757 Revenue and other income 320,446 288,138

Blackmores is the leading natural healthcare company across the Asia-Pacific region. Blackmores’ operations include product innovation and formulation, sourcing of the highest quality ingredients, quality programs to ensure compliance with standards of good manufacturing and the marketing, sales and distribution of products to customers and consumers.

02 OUR OPERATIONS

Accounting policiesRevenueRevenue is measured at the fair value of the consideration received or receivable. Revenue is reduced for discounts, estimated customer returns, and promotional and other rebates.

Sale of goodsRevenue from the sale of goods is recognised when the performance obligation of the sale has been fulfilled and control of the goods has been transferred to the customer. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.

Sale of goods on consignmentRevenue from the sale of goods on consignment is recognised upon the sale of the goods by the consignee. Control of the goods remains with Blackmores until such time as the goods are sold by the consignee.

Discounts, promotional and other rebatesThe amount of revenue recognised for a transaction is net of any discounts, promotional and other rebates, which include growth rebates, and/or contributions to customers towards promotional activities (known as case deals).

2.2 SEGMENT INFORMATIONInformation reported to the Group’s Chief Operating Decision Maker for the purposes of resource allocation and assessment of segment performance is largely focused on geographical regions. The Group’s reportable segments under AASB 8 are therefore as follows:

ANZ Comprising the sales of the Blackmores, Pure Animal Wellbeing and Impromy brands across Australia and New Zealand, also including the benefit of sales made to customers which are ultimately intended for Asian markets.

CHINA Comprising the sales of the Blackmores and Pure Animal Wellbeing brand in China (in country) and China Export Division.

BIOCEUTICALS GROUP Comprising the BioCeuticals practitioner brands, Isowhey, Wheyless, Oriental Botanicals and Fusion Health brands.

OTHER ASIA Comprising the Blackmores and Pure Animal Wellbeing brands in Thailand, Malaysia, Singapore, Hong Kong, Taiwan, Korea, Indonesia, Vietnam, Cambodia and Kazakhstan.

CORPORATE COSTS Costs which cannot be reliably allocated to a specific segment, or which have been incurred for long-term growth opportunities.



2.2 SEGMENT INFORMATION (CONT.)

2.2.1 Revenue by segment



ANZ* 144,227 120,965 China 65,395 73,881 BioCeuticals Group 56,840 53,130 Other Asia 52,927 39,405 319,389 287,381

The Group had one customer who contributed more than 10% of the Group’s revenue in the period (2017: One). Revenue earned from this customer amounts to $83,365 thousand (2017: $63,413 thousand). This customer serves both the ANZ and BioCeuticals Group segments.

* ANZ segment includes ‘other’ in 2017 comparatives.

2.2.2 EBIT by segment



ANZ* 33,321 26,067 China 11,665 20,803 BioCeuticals Group 8,513 7,916 Other Asia 4,566 1,240 Corporate Costs (7,588) (6,774) 50,477 49,252 * ANZ segment includes ‘other’ in 2017 comparatives.

2.2.3 Revenue history by segment

ANZ

20

40

60

80

100

120

140

160

China BioCeuticals Group Other Asia

2017 half-year ended

2018 half-year ended

02 OUR OPERATIONS

$ m

illion

s



3.1 BUSINESS COMBINATIONS On 28 November 2018 Blackmores Group acquired the Impromy weight management product portfolio for $8.7 million.


31 December 2018 $’000

3.1.1 Consideration transferredCash 8,686

3.1.2 Assets acquired at date of acquisitionNon-current assets

Software 343 Intangible assets 1,372 1,715

3.1.3 Goodwill arising on acquisitionConsideration paid in cash 8,686 Less: Fair value of identifiable net assets acquired (1,715) 6,971

The business combination has been initially accounted for on a provisional basis, which will be retrospectively adjusted to also recognise additional assets or liabilities during the measurement period, based on new information obtained about the facts and circumstances that existed at the acquisition date. The measurement period ends on either the earlier of (i) 12 months from the date of the acquisition or (ii) when the acquirer receives all the information possible to determine the fair value.

3.1.4 Impact of acquisition on results of the GroupThe impact of the acquisition on the results of the Group is immaterial for the half-year ended 31 December 2018.

03 OUR INVESTMENTS

20190

10

20

30

40

50

60

70

80

2020 2021 2022

51% 49%

Blackmores Limited Debt Maturity Profile Debt Facilities



4.1 INTEREST-BEARING LIABILITIES

31 December 30 June 2018 2018 $’000 $’000

Non-current Bank loan Unsecured - at amortised cost 109,000 86,000

4.1.1 Reconciliation of liabilities arising from financing activities

31 December 30 June 2018 2018 $’000 $’000

Interest-bearing liabilitiesBalance at the start of the period/year 86,000 78,968 Net cash inflow 23,000 7,032 Balance at the end of the period/year 109,000 86,000

04 OUR FINANCING

Drawn Facilities $109m

Facility Expires by Calendar Year

$ m

illion

s

Undrawn Facilities $111m



4.2 DIVIDENDS

Half-year ended Half-year ended 31 December 2018 31 December 2017

CENTS PER TOTAL CENTS PER TOTAL SHARE $’000 SHARE $’000

Recognised amountsFully paid ordinary sharesFinal dividend declared in respect of prior financial year – fully franked at 30% corporate tax rate 155 26,587 140 24,117 - Paid as cash 19,811 24,117 - Taken as shares issued though Dividend Reinvestment Plan (DRP) 6,776 - 26,587 24,117Unrecognised Amounts Fully paid ordinary shares Interim dividend payable in respect of current financial year – fully franked at 30% corporate tax rate 150 25,945 150 25,840

The interim dividend in respect of ordinary shares for the year ending 30 June 2019 has not been recognised in these Consolidated Financial Statements because the interim dividend was declared subsequent to 31 December 2018.

4.3 SHAREHOLDER RETURNS HISTORY

04 OUR FINANCING

1H14

50

100

150

200

250

300

1H15 1H16 1H17 1H18 1H19

0

10

20

30

40

50

60

70

80

90

100

%

Cent

s

Dividends per share (cents)

Dividend payout ratio (%)

Earnings per share (cents)



5.1 FAIR VALUE OF FINANCIAL INSTRUMENTSThe Directors consider that the carrying amounts of financial assets and financial liabilities recognised at amortised cost in the Condensed Consolidated Financial Statements approximate their fair values.

Valuation techniques and assumptions applied for the purpose of measuring fair value The fair values of financial assets and financial liabilities are determined as follows:• the fair value of financial assets and financial liabilities with standard terms and conditions and traded on active liquid markets are

determined with reference to quoted market prices; • the fair value of derivative instruments are calculated using quoted prices. Where such prices are not available, a discounted cash

flow analysis is performed using the applicable yield curve for the duration of the instruments for non-optional derivatives and option pricing models for optional derivatives; and

• the fair value of other financial assets and financial liabilities (excluding derivative instruments) are determined in accordance with generally accepted pricing models based on discounted cash flow analysis using prices from observable current market transactions.

Fair value measurements recognised in the condensed consolidated statement of financial position The following table provides an analysis of financial instruments that are measured subsequent to initial recognition at fair value, grouped into Levels 1 to 3 based on the degree to which the fair value is observable. • Level 1 fair value measurements are those derived from quoted prices (unadjusted) in active markets for identical assets or liabilities.• Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable

for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices).• Level 3 fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not

based on observable market data (unobservable inputs).

31 December 30 June 2018 2018 $’000 $’000

Financial assets Unquoted equities Level 3 1,419 1,355 Foreign exchange derivatives Level 1 664 449 Interest rate derivatives Level 1 - 26 2,083 1,830 Financial liabilities Foreign exchange derivatives Level 1 169 60Interest rate derivatives Level 1 142 143 311 203

05 FINANCIAL INSTRUMENTS



6.1 CONTINGENT LIABILITIES Blackmores remains in active discussions with relevant authorities in Australia and in one of the countries in which it trades, pertaining to the historical use of and compliance to, export classification codes and related exemptions claimed under free trade agreements. These discussions have been ongoing for over 12 months and continue to progress. Blackmores expects a resolution to be reached in the 2019 calendar year. At signing date, no conclusions have been reached with the relevant regulatory bodies. A reliable estimate of potential risks or probable outflows as an outcome of this review cannot be determined. Accordingly, no liability has been recorded in the accounts as at 31 December 2018.

6.2 EVENTS AFTER THE REPORTING PERIOD

Interim dividendThe Directors declared a fully franked dividend of 150 cents per share on 18 February 2019 as described in note 4.2.

06 OTHER

Blackmores Limited Australia’s Leading Natural Health Company ACN 009 713 437

20 Jubilee Avenue Warriewood NSW 2102, Australia Phone: +61 2 9910 5000 Fax: +61 2 9910 5555

blackmores.com.au

appendix 4d - blackmores

Documents